ASP Isotopes Signs Agreement with Gates-Backed TerraPower for HALEU Facility, Stock Up 46%, 23% in Pre-Market

Oct 30, 2024, 11:19 AM

ASP Isotopes Inc. (ASPI) has signed a term sheet with Gates-Backed TerraPower, LLC to fund the construction of a High Assay Low-Enriched Uranium (HALEU) production facility. This strategic agreement aims to commercialize and purchase HALEU, which is crucial for next-generation nuclear fuel. The announcement has led to a significant increase in ASPI's stock, which is up 46% in pre-market trading. The company has also been making strides in quantum enrichment technologies and has contracts for Carbon-14, Molybdenum-100, and Silicon-28 production, with potential revenues of $12-30 million in 2024. ASPI's proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment technologies are key to its recent success. Additionally, ASPI's stock is running sharply higher by 23% in pre-market trading, and it achieved its milestones 5X faster than projected.